ALKS


FDA Stuns Alkermes Plc (ALKS) With Refusal to File Letter for Depression Treatment ALKS 5461; Shares Tumble 20%

Shares of Alkermes Plc (NASDAQ:ALKS) fell nearly 20 percent in early Monday trading after the FDA stunned the company with a Refusal to …

Credit Suisse Bullish on Alkermes Plc (ALKS) as It Takes a Leap FORWARD

As the healthcare community debates the positive top line results from Alkermes Plc (NASDAQ:ALKS) FORWARD-5 study for ALKS 5461 in major depressive disorder, Credit Suisse analyst …

Analysts Change Price Targets for Two Biotech Stocks: Alkermes Plc (ALKS), Rigel Pharmaceuticals, Inc. (RIGL)

Alkermes Plc All eyes today on Alkermes Plc (NASDAQ:ALKS) as the biopharmaceutical company announced positive phase 3 data for ALKS 5461, a pipeline drug …

Company Update (NASDAQ:ALKS): Here’s Why Alkermes Plc Shares Jumped 40% Today

Alkermes Plc (NASDAQ:ALKS) investors have a smile on their faces Thursday evening, after the drug maker announced positive topline results from its FORWARD-5, the third core efficacy trial …

J.P. Morgan Heads to Sidelines on Alkermes Plc (ALKS); Slashes Price Target

In a research report published Tuesday afternoon, J.P.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts